Researchers Successfully Convert Human Skin Cells Into Embryonic Stem Cells
[WATCH VIDEO: Contracting Cardiomyocystes] redOrbit Staff & Wire Reports - Your Universe Online Researchers at Oregon Health & Science University (OSHU) and the Oregon National Primate Research Center (ONPRC) have successfully...
Latest biotechnology Stories
Cellars Wine Club provides a new guide with 3 simple steps to ideal wine club storage in a article for wine enthusiasts. Seattle, WA (PRWEB) May 17, 2013 Properly storing your new wine club wine may be a new concept for many new wine club members. Cellars Wine Club has released a simple three step guide to Ideal Wine Club Storage to help wine club members enjoy the absolute tastes of their wine club wine shipments. Wine is perishable, and as the guide states, “Incorrect storage, even...
CHAMPAIGN, Ill., May 17, 2013 /PRNewswire/ -- Sony Biotechnology Inc. ("Sony") today announced the launch of the new SH800 Cell Sorter 8-well strip holder and 130um sorting chip. Sony will also be exhibiting its newly rebranded reagent portfolio. New data collected on its new SH800 Cell Sorter, the EC800 flow cytometer, and new SP6800 Spectral Analyzer will be presented during commercial tutorials at CYTO 2013, which will be held at the San Diego Convention Center in San Diego,...
PALO ALTO, Calif., May 17, 2013 /PRNewswire/ -- Cellular Biomedicine Group (OTCQB: CBMG) today announced that it has achieved 50% enrollment of the total projected enrollment required for its Phase I trial to evaluate the safety and preliminary efficacy of the medical technology haMPC (Human Adipose-derived Mesenchymal Progenitor Cells) therapy for Knee Osteoarthritis (KOA). To date the trial has had no Severe Adverse Effect (SAE) reported. The Phase I open label clinical research...
SAN JOSE, Calif., May 17, 2013 /PRNewswire-iReach/ -- Aridis is pleased to announce that an agreement has been reached with Switzerland-based Kenta Biotech to acquire Kenta's entire portfolio of anti-infective human monoclonal antibody (mAb) products, and technologies. This asset portfolio purchase includes six anti-infective human mAb products for treatment of infections by common pathogens including drug resistant bacterial strains of Staphylococcus aureus, Pseudomonas aeruginosa,...
BioInformatics LLC announces the release of their newest market report: The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities. Arlington, VA (PRWEB) May 16, 2013 BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004) With barriers to entry low, the number of suppliers in the primary cells market continues to increase. In this study, BioInformatics LLC examines...
In a study just published in STEM CELLS Translational Medicine, researchers have found a new way to increase the survival of stem cells injected into the brain. The discovery might one day prove useful in developing new treatments for neurological disorders — especially brain lesions, which among other things can provoke seizures and indicate multiple sclerosis or certain forms of cancer. Durham, NC (PRWEB) May 16, 2013 Researchers have found a new way to increase the survival of stem...
Program will now focus on utilizing SGI expertise in synthetic genomics to enhance algae LA JOLLA, Calif., May 16, 2013 /PRNewswire/ -- Synthetic Genomics Inc. (SGI), a privately held company dedicated to developing genomic-driven solutions to address global challenges, today announced a new co-funded research agreement with ExxonMobil to develop algae biofuels. The new agreement is a basic science research program that focuses on developing algal strains with significantly improved...
Pressure BioSciences' PCT Platform Enhances Study Results SOUTH EASTON, Mass., May 16, 2013 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced the publication in the journal Analytical Chemistry of a study by a team of scientists led by Dr. Bruce Kristal, Associate Professor of Surgery at Harvard Medical School and the Department of Neurosurgery at Brigham and Women's Hospital, entitled: Method Development for Fecal Lipidomics...
ROCKVILLE, Md., May 16, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that CEO and President, Richard Garr, will present at the Annual World Stem Cells and Regenerative Medicine Congress on Thursday, May 23, in London, UK. Mr. Garr's talk, "Understanding the Practicalities of Using Innovative Therapies on Patients," at 2:05 PM, will explore how cell therapies will be used by clinicians and integrated into hospital settings...
LA JOLLA, Calif. and SHANGHAI, May 16, 2013 /PRNewswire/ -- RuiYi Inc. announced today that it has entered into an exclusive license and collaborative development agreement with Genor BioPharma for the development of RYI-008 in China. RYI-008 is a novel anti-IL-6 monoclonal antibody with a unique pharmacologic profile that has the potential to define a new paradigm in the treatment of autoimmune diseases and cancer. "RYI-008, with its unprecedented femtamolar potency and amazing long...
Latest biotechnology Reference Libraries
Biotechnology and Applied Biochemistry is a peer-reviewed academic journal established in 1979 under the title Journal of Applied Biochemistry and published by Academic Press. It assumed its present title in 1986 and publication was taken over by Portland Press in 1993. It is now published bimonthly by Wiley-Blackwell (since 2011). It is the official journal of the International Union of Biochemistry and Molecular Biology. The journal publishes scholarly Articles and Reviews relating to...
Cell is a peer-reviewed scientific journal founded by Benjamin Lewin in January 1974 with the sponsorship of MIT Press. Lewin bought the rights to the journal in 1986 and published it under his own publishing arm Cell Press. Cell Press was sold to Elsevier in 1999, which currently publishes Cell twice monthly. Cell Press publishes several biomedical journals, including Cell, Neuron, Immunity, Molecular Cell, Developmental Cell, Cancer Cell, Current Biology, Structure, Chemistry &...
Agrobacterium tumefaciens is the causal agent of crown gall disease (the formation of tumours) in over 140 species of dicot. It is rod shaped. Symptoms are caused by the insertion of a small segment of DNA into the plant cell. It is an alphaproteobacterium of the family Rhizobiaceae which includes the nitrogen fixing legume symbionts. They are pathogenic and provide no benefit to the plant. It also affects a wide variety of plants. In an economical sense it affects walnuts, grape vines,...
